Interim results for phase 1b dose expansion of Mtl-Cebpa in combination with pembrolizumab in patients with advanced solid tumour malignancies
Plummer, R. Sodergren, M. Ryan, B. Tachkov, I. Reebye, V. Meyer, T. Pinato, D. Sarker, D. Basu, B. Blagden, S.
Plummer, R.
Sodergren, M.
Ryan, B.
Tachkov, I.
Reebye, V.
Meyer, T.
Pinato, D.
Sarker, D.
Basu, B.
Blagden, S.
Citations
Altmetric:
Abstract
Authors
Plummer, R.
Sodergren, M.
Ryan, B.
Tachkov, I.
Reebye, V.
Meyer, T.
Pinato, D.
Sarker, D.
Basu, B.
Blagden, S.
Cook, Natalie
Evans, J.
Yachnin, J.
Chee, C. E.
Li, D. N.
El-Khoueiry, A.
Diab, M.
Huang, K. W.
D'Alessio, A.
Fulgenzi, C.
Noel, M.
Keenan, B.
Mahalingam, D.
Raulf, N.
Hogson, R.
Tan, C. P.
Nicholls, J.
Adderkin, A.
Vassiliadou, J.
Habib, R.
Rossi, J.
Habib, N.
Sodergren, M.
Ryan, B.
Tachkov, I.
Reebye, V.
Meyer, T.
Pinato, D.
Sarker, D.
Basu, B.
Blagden, S.
Cook, Natalie
Evans, J.
Yachnin, J.
Chee, C. E.
Li, D. N.
El-Khoueiry, A.
Diab, M.
Huang, K. W.
D'Alessio, A.
Fulgenzi, C.
Noel, M.
Keenan, B.
Mahalingam, D.
Raulf, N.
Hogson, R.
Tan, C. P.
Nicholls, J.
Adderkin, A.
Vassiliadou, J.
Habib, R.
Rossi, J.
Habib, N.
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Plummer R, Sodergren M, Ryan B, Tachkov I, Reebye V, Meyer T, et al. Interim Results for Phase 1b Dose Expansion of Mtl-Cebpa in Combination with Pembrolizumab in Patients with Advanced Solid Tumour Malignancies. Journal for immunotherapy of cancer. 2022 Nov;10:A888-A9. PubMed PMID: WOS:000919423400804.